Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Maurel

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal studyJavier García-Corbacho, Alberto Indacochea, Iván Victoria, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 24, 2005
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)Joan Maurel Santasusana, José Luis García López, Juan José García, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)Javier Martín, Andrés Poveda, Antonio Llombart-Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomasJoan Maurel, Antonio López-Pousa, Ramón de Las Peñas, et al.
World Journal of Gastroenterology|November 18, 2014
Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiationXabier García-Albéniz, Rosa Gallego, Ralf Dieter Hofheinz, et al.
Molecular & Cellular Proteomics : MCP|February 29, 2020
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular ClassificationLucía Trilla-Fuertes, Ismael Ghanem, Angelo Gámez-Pozo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2012
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic targetEnrique Casado, Victor Moreno Garcia, Jose Javier Sánchez, et al.
Translational Oncology|May 19, 2020
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell CarcinomaLucía Trilla-Fuertes, Ismael Ghanem, Joan Maurel, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 28, 2025
Effect of the composite quality resection score for rectal cancer on oncological outcomes in a multicentre cohort study (CRONOS)Yoelimar Guzmán, Jesús Paredes, Paula González-Atienza, et al.
Oncotarget|March 10, 2015
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patientsTeodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal studyJavier García-Corbacho, Alberto Indacochea, Iván Victoria, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 24, 2005
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)Joan Maurel Santasusana, José Luis García López, Juan José García, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS)Javier Martín, Andrés Poveda, Antonio Llombart-Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomasJoan Maurel, Antonio López-Pousa, Ramón de Las Peñas, et al.
World Journal of Gastroenterology|November 18, 2014
Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiationXabier García-Albéniz, Rosa Gallego, Ralf Dieter Hofheinz, et al.
Molecular & Cellular Proteomics : MCP|February 29, 2020
Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular ClassificationLucía Trilla-Fuertes, Ismael Ghanem, Angelo Gámez-Pozo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2012
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic targetEnrique Casado, Victor Moreno Garcia, Jose Javier Sánchez, et al.
Translational Oncology|May 19, 2020
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell CarcinomaLucía Trilla-Fuertes, Ismael Ghanem, Joan Maurel, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 28, 2025
Effect of the composite quality resection score for rectal cancer on oncological outcomes in a multicentre cohort study (CRONOS)Yoelimar Guzmán, Jesús Paredes, Paula González-Atienza, et al.
Oncotarget|March 10, 2015
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patientsTeodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
Pageof 12